Prospective assessment of fetal–maternal cell transfer in miscarriage and pregnancy termination
Author(s) -
Suzanne E. Peterson,
J. Lee Nelson,
Katherine A. Guthrie,
Vijayakrishna K. Gadi,
Tessa M. Aydelotte,
Deborah Oyer,
Sarah Prager,
Hilary S. Gammill
Publication year - 2012
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/des244
Subject(s) - microchimerism , fetus , pregnancy , miscarriage , obstetrics , andrology , medicine , cell free fetal dna , biology , prenatal diagnosis , genetics
Fetal cells (microchimerism) are acquired by women during pregnancy. Fetal microchimerism persists decades later and includes cells with pluripotent capacity. Persistent microchimerism has the capacity for both beneficial and detrimental maternal health consequences. Both miscarriage and termination of pregnancy can result in fetal microchimerism. We sought to determine whether cellular fetal microchimerism is acquired during management of pregnancy loss and further explored factors that could influence fetal cell transfer, including viability of fetal tissue, surgical versus medical management and gestational age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom